# reload+after+2024-01-20 03:47:21.201100
address1§Tower A
address2§2nd Floor 20 Raul Wallenberg Street
city§Tel Aviv
zip§6971916
country§Israel
phone§972 3 7175777
website§https://scisparc.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and epilepsy and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation, as well as a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. The company was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
fullTimeEmployees§3
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Oz  Adler CPA', 'age': 36, 'title': 'CEO & CFO', 'yearBorn': 1987, 'fiscalYear': 2022, 'totalPay': 422000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Itschak  Shrem', 'age': 76, 'title': 'President & Director', 'yearBorn': 1947, 'fiscalYear': 2022, 'totalPay': 499000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Adi  Zuloff-Shani Ph.D.', 'age': 54, 'title': 'Chief Technologies Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 351000, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.387
priceToSalesTrailing12Months§0.7622317
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§SciSparc Ltd.
longName§SciSparc Ltd.
firstTradeDateEpochUtc§1630330200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§b2a522aa-80bd-37e6-bfd1-c01dcdeec0b1
gmtOffSetMilliseconds§-18000000
recommendationKey§none
quickRatio§0.944
grossMargins§0.52124
ebitdaMargins§-1.8101801
trailingPegRatio§None
